H3 Health Hub’s Post

Only 3 weeks until the 24th BioEquity Europe in San Sebastian, Spain. Please register now -- before it sells out! Partnering is open, 130+ biotechs confirmed to present, only a few slots left on our pre-event networking excursions (first-come, first-served). ✅ Register: https://lnkd.in/gSxxhu7 ✳️ One area to highlight -> This year's agenda focuses on: How can #biotechs "rise above the noise" to attract the right investors, partners and talent? Recent additions to the faculty, include: ➢ Arjen Lemmen of argenx ➢ Arno de Wilde of EQT Group ➢ Caroline Gaynor of Lightstone Ventures ➢ Christina Takke of V-Bio Ventures ➢ Claire Brown of Oxford Science Enterprises ➢ Dmitry 'Dima' Kuzmin of 4BIO Capital ➢ Elise Peters of Syncona Limited ➢ Florent Gros of Earlybird Venture Capital ➢ Franck Le Deu of McKinsey & Company ➢ Frank Kalkbrenner of Boehringer Ingelheim ➢ Jason P. Hafler of Sanofi ➢ Joep Muijrers of Gilde Healthcare ➢ Jonathan Tobin of Brandon Capital ➢ Karen Wagner of Ysios Capital ➢ Ksenija Pavletic of JEITO ➢ Nerida Scott of Johnson & Johnson ➢ Nina Rawal of Trill Impact ➢ Paulo Fontoura of Roche ➢ Dr. Shanshan Xu of BioNTech SE ➢ Søren Møller of Novo Nordisk And many more... I hope you will join BioCentury and EBD Group at this destination event for #biotech CEOs and investors. No event has a larger concentration of VCs than BioEquity. Please DM me if you have any questions. See you soon in San Sebastian! #venturecapital #drugdevelopment #biopharma #BioEquityEurope

🔬 Connecting Biotech Innovation with Nordic Investors 🔬 🤝 At Scandinavian Alliance, we connect groundbreaking biotech companies with Nordic investors who recognize the transformative potential of life sciences. With the Nordic region being a global leader in biotech innovation, securing the right investors is crucial for companies aiming to advance their development and scale their impact. 💡 What We Offer: 1️⃣ Strategic Connections – Linking biotech companies with investors who share their vision for innovation and long-term growth. 2️⃣ Growth-Oriented Partnerships – Our investor network is actively looking for opportunities in areas such as drug development, diagnostics, and health tech integration. 3️⃣ Sustainable Investment Focus – Nordic investors prioritize ESG-aligned biotech initiatives, ensuring ethical and sustainable growth. Driving Biotech Growth We’ve helped biotech companies secure funding to advance their development, accelerate clinical trials, and expand their market reach. With investor interest in biotech at an all-time high, now is the time to explore new opportunities.

Create connections that lead to successful collaborations – Upcoming events powered by partneringONE® Are you ready to take your partnering and business development to the next level? Join us at these must-attend events in 2025, where partneringONE will help you connect with the right people, foster collaborations, and drive innovation in life sciences and beyond. Mark Your Calendar for These Key Events: 🔬 BioSeed 2025 – The premier platform for early-stage biotech innovators. 💸 OBIO Investment Summit – Where life sciences companies meet investment opportunities. 🛡️ AMR Conference – Bringing new antimicrobial treatments and diagnostics to the market. 🧬 RNA Leaders Europe – Shaping the future of RNA therapeutics. 💡 Investival Showcase USA – Where Visionary Life-Science Innovators Secure Game-Changing Capital and Partnerships 🌼 BIO-Europe Spring – The essential gathering for cultivating thriving strategic partnerships Whether you’re seeking investors, forging strategic partnerships, or looking for services to help your business grow, partneringONE ensures your time at these events is efficient, productive, and impactful. Don’t miss the chance to elevate your partnering game in 2025. 📖 Learn more about these events and how partneringONE is powering connections: http://spr.ly/6046a1x0m Which event are you most excited to attend? Let us know in the comments! 👇 #partneringONE #LifeSciences #NetworkingEvents #Innovation #Biotech #Partnerships

Unlock the secrets to successful partnerships in the biotech sector! 🎙️ In this episode of BIO from the BAYOU, we sit down with Tari Suprapto, PhD, Director of Search and Evaluation at Novo Nordisk, who shares her strategies for fostering strong academic-corporate relationships – tips that also work for many smaller companies talking to larger ones. Learn how to navigate the challenges of communication, align goals, and overcome imposter syndrome in high-stakes environments. 🚀 Listen now to gain actionable insights on building and maintaining impactful partnerships in biotech! 🔗 Link in comments ➡️ #Biotech #Partnerships #Innovation #AcademicResearch #CorporateCollaboration #ImposterSyndrome #NovoNordisk

Energized by an incredible week of innovation and collaboration at #BiotechShowcase 2025 and #BIO@JPM in San Francisco! 🌉   Amy Baker Mandragouras, Stacie Aarestad, Brendan Burke, Patrick Connolly, Mark Potash, and Ryan M. Rourke Reed had the privilege of connecting with groundbreaking biotech companies, innovative startups, and industry leaders who are shaping the future of life sciences. The discussions centered on emerging therapeutic areas, novel drug development approaches, and the evolving regulatory landscape demonstrated the remarkable momentum in the life sciences sector.   Key highlights from our meetings:  ✨ Engaged in meaningful discussions about strategic partnerships and funding opportunities in the current market ✨ Explored evolving legal considerations in AI/ML applications in drug discovery and development ✨ Had compelling discussions about IP strategy and portfolio development – a critical priority for companies looking to protect their innovations and attract investment   The entrepreneurial spirit and scientific excellence on display this week reinforced why the life sciences sector continues to drive transformative healthcare solutions. We are grateful for the opportunity to support these visionary companies as they work to bring life-changing treatments to patients.

🌟 LSX World Congress – 𝗗𝗮𝘆 𝟭: 𝗨𝗻𝗹𝗲𝗮𝘀𝗵𝗶𝗻𝗴 𝘁𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗕𝗶𝗼𝘁𝗲𝗰𝗵! 🌟 🌱 Today, Ken C., Life Sciences Counsel at the London office, attended the LSX World Congress, where he connected with fascinating biotech companies during partner meetings and where he attended inspiring panel discussions. 🚀 Ablynx and Galapagos: Two names that echoed across the room. These companies, hailing from Flanders, have proven that, contrary to popular belief, 𝐭𝐡𝐞 𝐩𝐚𝐭𝐡 𝐭𝐨 𝐭𝐫𝐢𝐮𝐦𝐩𝐡 𝐢𝐧 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐢𝐬𝐧’𝐭 𝐬𝐨𝐥𝐞𝐥𝐲 𝐩𝐚𝐯𝐞𝐝 𝐰𝐢𝐭𝐡 𝐚 𝐟𝐢𝐫𝐬𝐭 𝐥𝐢𝐬𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐒. Their Flemish beginnings paved the way for global triumphs! 📈 Flanders was their starting point. Both Ablynx and Galapagos made their 𝐝𝐞𝐛𝐮𝐭 𝐨𝐧 𝐁𝐞𝐥𝐠𝐢𝐚𝐧 𝐬𝐭𝐨𝐜𝐤 𝐞𝐱𝐜𝐡𝐚𝐧𝐠𝐞𝐬 𝐛𝐞𝐟𝐨𝐫𝐞 𝐞𝐦𝐛𝐚𝐫𝐤𝐢𝐧𝐠 𝐨𝐧 𝐭𝐡𝐞𝐢𝐫 𝐠𝐥𝐨𝐛𝐚𝐥 𝐣𝐨𝐮𝐫𝐧𝐞𝐲. And guess what? Their strategic moves paid off! 🔍 Ablynx: Acquired by Sanofi after making waves in Flanders. 📊 Galapagos: Soared to the Nasdaq, captivating investors worldwide. 👀 Looking forward to 𝗗𝗮𝘆 𝟮!

💰 Biotech Early Round Funding Activity ($1M+) - 1H 2024 We analyzed early-round biotech funding data from our online BiopharmIQ platform. See the recent funding activity: https://lnkd.in/g6rEmde3 Early round = Angel/pre-Seed, Seed, Series A 1st half 2024 Not surprisingly: ⇒ U.S. was at the top of the list (29 companies). Surprising? ⇒ UK (9 co) and China (9 co) had almost 1/3 as many companies as U.S. ⇒ Switzerland (7 co) was next on the list. ⇒ Canada (4 co) had twice as many companies as France (2 co). ⇒ Germany has 0 companies. For more details and more graphical data, see our blog post https://lnkd.in/giriKX84 Have questions or want to schedule an online demo? Contact marketing@biopharmiq.com

Very pleased to share that I will represent Solas BioVentures in the UK's "MedTech Accelerator Initiative: Rapid Regulatory Support (MARRS)", funded by the Department for Science, Innovation and Technology (DSIT) and the Office for Life Sciences (OLS). Our expert committee will inform government policies to tackle industry challenges and shape the future of investment and innovation in the MedTech sector in the UK. The initiative will start next week and is coordinated by CPI.

BioSparkVA is a competitive live pitch event for life sciences start-ups, co-hosted by CvilleBioHub.  The event will be held Thursday, September 26, 2024  at 9:00 am at the Irving Theater, 225 W. Water Street in Charlottesville. Our 2nd annual pitch competition for life-science start-ups co-hosted with Cooley. Applications are open and there is a $10k cash prize for the first place winner. BioSparkVA Eligibility Criteria ▶ Companies must be U.S.-based and willing to present in person on Sept 26th ▶ Open to established entities that have raised or been granted $100k to $10M in total funding ▶ Companies may only enter one product or service The submitted product or service must fall under one of the following categories: ▶ Therapeutics ▶ Digital Health ▶ Medical Device ▶ Diagnostics ▶ Healthcare Adjacent Tech Learn more and apply: https://lnkd.in/eVsZXZZw

🎓 The Top 10 Biotech Powerhouses of 2024 Are Here! 🌍 🧬 Biotech is shaping our future, from groundbreaking medicines to sustainable solutions. ✨ But here’s the big question: If you had to choose ONE of these institutions to study or collaborate with, which would it be—and why? 🤔 Share your pick below! 👇